RxDoctor Payments Data
★ My doctorsLook up a doctor →

Luis Vaccarello

Gynecologic Oncology · Columbus, OHNPI 1225034622

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (56.6%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 58 manufacturers reported payments, led by Seagen Inc. at 46.6% of the total. Reporting peaked in 2020 at $5,902 and has fallen 98.5% since, to $91 in 2025.

$11,595in general payments, 2019–2025

Across 187 payments — averaging $62.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Seagen Inc.$5K
  • GSK$728
  • AstraZeneca$606
  • Merck$432
  • Eisai Inc.$395
  • Astellas Pharma US Inc$292
  • plus $4K from 52 others

What the payments were for

  • Consulting fees$4,50039%
  • Travel & lodging$4964%
  • Food & beverage$6,56857%
  • Education$320%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Seagen Inc.15$5,409
GSK8$728
AstraZeneca(2 entities)11$606
Merck11$432
Eisai Inc.23$395
Astellas Pharma US Inc4$292
Genentech USA, Inc.7$274
AbbVie(2 entities)3$235
Therapeuticsmd, Inc.2$229
Heron Therapeutics, Inc.1$216
Genmab U.S., Inc.2$204
Daiichi Sankyo Inc.4$199
Tesaro, Inc.4$170
Sage Therapeutics, LLC1$160
Takeda Pharmaceuticals U.S.A., Inc.10$153
Minerva Surgical, Inc2$130
Sumitomo Pharma America, Inc.1$125
Myovant Sciences Inc.1$122
Medical Device Business Services, Inc.1$117
Taiho Oncology, Inc.8$106
Clovis Oncology, Inc.2$91
Biogen1$91
Johnson & Johnson(2 entities)5$76
Ipsen Biopharmaceuticals, Inc3$65
Novartis4$63
Bristol Myers Squibb3$53
Karyopharm Therapeutics Inc.3$52
Incyte Corporation2$48
Sanofi3$48
Jazz Pharmaceuticals Inc.2$47
Coherus Oncology, Inc.3$46
Pharmaessentia USA Corporation2$41
Amgen3$40
Exelixis Inc.2$39
Dendreon Pharmaceuticals LLC3$37
EMD Serono, Inc.2$34
Boehringer Ingelheim2$29
Array Biopharma Inc1$29
ADC Therapeutics America, Inc.2$29
Foundation Medicine, Inc.2$27
Springworks Therapeutics, Inc.1$27
Beigene USA, Inc.1$27
Pfizer1$23
Blue Earth Diagnostics1$22
Regeneron Healthcare Solutions, Inc.1$18
Tersera Therapeutics LLC1$18
Pharmacyclics LLC, An Abbvie Company1$17
Sobi, Inc1$17
Agios Pharmaceuticals, Inc.1$17
Tolmar Pharmaceuticals, Inc.1$15
Immunogen, Inc.1$15
E.r. Squibb & Sons, L.L.C.1$15
Servier Pharmaceuticals LLC1$14
Gilead1$14
Helsinn Therapeutics (U.S.), Inc.1$13
Kyowa Kirin, Inc.1$13
Dova Pharmaceuticals1$13
Aurobindo Pharma USA, Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,595 in reported general payments places this provider in the 80th percentile of 62 gynecologic oncology providers in Ohio.

See all gynecologic oncology providers in Ohio →

Other gynecologic oncology in Columbus

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →